Ampicillin Sodium/Tazobactam Sodium

氨苄西林钠/他唑巴坦钠

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAmpicillin Sodium/Tazobactam Sodium
Drug Alias NameTazobactam Sodium+Ampicillin Sodium他唑巴坦钠氨苄西林钠Ampicillin Sodium+Tazobactam Sodium氨苄西林钠他唑巴坦钠Tazobactam Sodium/Ampicillin Sodium +[10] 
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Tazobactam SodiumAmpicillin Sodium
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesHainan General & Kangli Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHainan General & Kangli Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A